Dendritic vaccines are considered a promising area of cancer treatment. The prostate cancer vaccine has been used for more than a decade in clinics in developed countries as a standard treatment for the metastatic disease stage. Many other dendritic vaccines are not yet approved, but are already being used in developed countries as part of clinical trials. You can travel abroad to take advantage of all the possibilities of modern oncology. You can choose a clinic for dendritic cell cancer therapy in Germany on the Booking Health website.
What are dendritic cells?
Dendritic cells are a type of white blood cells (immune cells) that contain many outgrowths. Their main function is to present antigens to T-cells. Without dendritic cells, T-cells cannot fully perform their functions because they are unable to recognize cancer antigens and destroy malignant neoplasms.
Ralph Steinman received the Nobel Prize for the discovery of dendritic cells in 2011, which highlights the importance of this discovery. Today they are used in the fight against malignant neoplasms. Some dendritic cell vaccines have already been approved and are part of the standard treatment protocol, although most are still undergoing clinical trials.
The principle of dendritic cell cancer treatment
Vaccines are made individually from the patient's blood components. First, dendritic cells are harvested from the blood. They are then activated with tumor antigens to "teach" them to recognize cancer, distinguishing it from normal tissue. Once the "trained" dendritic cells have been introduced into the human body, they pass on their "knowledge" to T-cells, showing them which antigens to attack. T-cells then begin to actively destroy the initial tumor and its metastases.
Dendritic cell vaccines do not cure cancer, but they can shrink tumors and slow their growth. As a result, doctors can increase patients' life expectancy, reduce the risk of tumor recurrence, or extend the recurrence-free period.
Dendritic cells in cancer immunotherapy can be used as a stand-alone treatment, but are more often combined with other cancer therapies: chemotherapy, targeted therapy, and other immune therapy options, most often immune checkpoint inhibitors.
What treatment with dendritic cells is indicated
The first vaccine has already been approved in Europe and North America for the treatment of prostate cancer. It has been successfully used in many cancer centers. The vaccine increases the life expectancy of patients with metastatic disease.
Other vaccines are still under investigation. They are available as a part of clinical trials. Cancers for which dendritic cell vaccines have already been developed are:
- Breast, kidney, lung and pancreatic cancer
- Osteosarcoma
- Colorectal cancer
- Melanoma
- Mesothelioma
- Glioblastoma and other central nervous system tumors
To undergo cutting-edge diagnostics and cancer treatment with dendritic cell vaccines without long waiting, you can apply to one of the leading German clinics specializing in immunotherapy. Check the cost of dendritic cell cancer treatment in Germany on the Booking Health website, which provides transparent prices and facilitates medical travel arrangements. Our team will help you find a reputable clinic with a center for cell technologies, utilizing the latest methods in cancer immunotherapy and boasting impressive treatment outcomes.
After selecting the most suitable healthcare facility, Booking Health will fully organize your medical trip, handling all logistics, including travel arrangements, accommodation, translation services, and appointment scheduling. With our assistance, you can focus on your healing journey while we take care of the intricate details, ensuring a seamless and stress-free experience. Germany's expertise in dendritic cell cancer therapy, combined with our comprehensive support, offers you a promising path to recovery in a timely and convenient manner.
